Douglas S. Conklin

6.3k total citations · 3 hit papers
52 papers, 5.0k citations indexed

About

Douglas S. Conklin is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Douglas S. Conklin has authored 52 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 11 papers in Genetics and 9 papers in Cancer Research. Recurrent topics in Douglas S. Conklin's work include RNA Interference and Gene Delivery (10 papers), RNA and protein synthesis mechanisms (7 papers) and Fungal and yeast genetics research (7 papers). Douglas S. Conklin is often cited by papers focused on RNA Interference and Gene Delivery (10 papers), RNA and protein synthesis mechanisms (7 papers) and Fungal and yeast genetics research (7 papers). Douglas S. Conklin collaborates with scholars based in United States, Iran and France. Douglas S. Conklin's co-authors include Gregory J. Hannon, Patrick J. Paddison, Amy A. Caudy, Emily Bernstein, Thu-Thao T. Pham, Anton P. McCaffrey, Leonard Meuse, Mark A. Kay, Michael R. Culbertson and Antonis Kourtidis and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Douglas S. Conklin

52 papers receiving 4.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells

2002 1.2k citations Patrick J. Paddison, Amy A. Caudy et al. Genes & Development profile →
RNA interference in adult mice

2002 849 citations Anton P. McCaffrey, Leonard Meuse et al. Nature profile →
A resource for large-scale RNA-interference-based screens in mammals

2004 554 citations Patrick J. Paddison, Douglas S. Conklin et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Douglas S. Conklin United States	27	4.0k	883	842	503	365	52	5.0k
Siavash K. Kurdistani United States	38	6.1k 1.5×	708 0.8×	717 0.9×	798 1.6×	627 1.7×	62	7.2k
Harry Vrieling Netherlands	43	4.0k 1.0×	746 0.8×	1.2k 1.4×	967 1.9×	396 1.1×	117	5.5k
Graham Dellaire Canada	43	4.9k 1.2×	597 0.7×	551 0.7×	865 1.7×	409 1.1×	123	6.2k
Vicente Notario United States	31	2.4k 0.6×	413 0.5×	583 0.7×	913 1.8×	239 0.7×	106	3.8k
Meng‐Er Huang France	31	3.6k 0.9×	520 0.6×	329 0.4×	357 0.7×	207 0.6×	73	4.5k
Traver Hart United States	28	3.8k 1.0×	456 0.5×	819 1.0×	671 1.3×	114 0.3×	61	4.8k
Berend Snijder Switzerland	23	2.4k 0.6×	276 0.3×	729 0.9×	508 1.0×	259 0.7×	56	3.9k
Tiziana Bonaldi Italy	39	4.6k 1.2×	432 0.5×	582 0.7×	574 1.1×	304 0.8×	114	6.5k
Lukas E. Dow United States	38	4.1k 1.0×	787 0.9×	812 1.0×	1.3k 2.5×	123 0.3×	73	6.0k
Jean Mosser France	39	2.8k 0.7×	401 0.5×	658 0.8×	860 1.7×	171 0.5×	115	5.1k

Countries citing papers authored by Douglas S. Conklin

Since Specialization

Citations

This map shows the geographic impact of Douglas S. Conklin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas S. Conklin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas S. Conklin more than expected).

Fields of papers citing papers by Douglas S. Conklin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas S. Conklin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas S. Conklin. The network helps show where Douglas S. Conklin may publish in the future.

Co-authorship network of co-authors of Douglas S. Conklin

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas S. Conklin. A scholar is included among the top collaborators of Douglas S. Conklin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas S. Conklin. Douglas S. Conklin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Baumann, Jan, et al.. (2018). Global metabolite profiling analysis of lipotoxicity in HER2/neu-positive breast cancer cells. Oncotarget. 9(43). 27133–27150. 11 indexed citations

Deng, Yanxiang, Steven Davis, Fan Yang, et al.. (2017). Microfluidics: Inertial Microfluidic Cell Stretcher (iMCS): Fully Automated, High-Throughput, and Near Real-Time Cell Mechanotyping (Small 28/2017). Small. 13(28). 5 indexed citations

Sevinsky, Christopher J., et al.. (2016). Bruton's Tyrosine Kinase Inhibitors Prevent Therapeutic Escape in Breast Cancer Cells. Molecular Cancer Therapeutics. 15(9). 2198–2208. 46 indexed citations

Baumann, Jan, et al.. (2016). Palmitate-induced ER stress increases trastuzumab sensitivity in HER2/neu-positive breast cancer cells. BMC Cancer. 16(1). 551–551. 34 indexed citations

Kokabee, Leila, Xianhui Wang, Christopher J. Sevinsky, et al.. (2015). Bruton's tyrosine kinase is a potential therapeutic target in prostate cancer. Cancer Biology & Therapy. 16(11). 1604–1615. 34 indexed citations

Baumann, Jan, et al.. (2015). Metabolic Assays for Detection of Neutral Fat Stores. BIO-PROTOCOL. 5(12). 6 indexed citations

Sun, Ying, et al.. (2013). PPARγ maintains ERBB2-positive breast cancer stem cells. Oncogene. 32(49). 5512–5521. 63 indexed citations

Breaker, Ronald R., Douglas S. Conklin, Larry Gold, et al.. (2012). RNA Science and its Applications—a look toward the future. RNA Biology. 9(8). 1050–1053. 2 indexed citations

Kourtidis, Antonis, et al.. (2010). An RNA Interference Screen Identifies Metabolic Regulators NR1D1 and PBP as Novel Survival Factors for Breast Cancer Cells with the ERBB2 Signature. Cancer Research. 70(5). 1783–1792. 67 indexed citations

10.

Kourtidis, Antonis, et al.. (2009). Peroxisome proliferator-activated receptor-γ protects ERBB2-positive breast cancer cells from palmitate toxicity. Breast Cancer Research. 11(2). R16–R16. 54 indexed citations

11.

Adam, Alejandro P., Ajish George, Denis M. Schewe, et al.. (2009). Computational Identification of a p38SAPK-Regulated Transcription Factor Network Required for Tumor Cell Quiescence. Cancer Research. 69(14). 5664–5672. 129 indexed citations

12.

Ranganathan, Aparna C., et al.. (2008). Dual Function of Pancreatic Endoplasmic Reticulum Kinase in Tumor Cell Growth Arrest and Survival. Cancer Research. 68(9). 3260–3268. 94 indexed citations

13.

Kourtidis, Antonis, et al.. (2007). xCT expression reduces the early cell cycle requirement for calcium signaling. Cellular Signalling. 20(2). 390–399. 21 indexed citations

14.

Kourtidis, Antonis, Cheryl Eifert, & Douglas S. Conklin. (2007). RNAi Applications in Target Validation. PubMed. 1–21. 9 indexed citations

15.

Conklin, Douglas S.. (2003). RNA‐Interference‐Based Silencing of Mammalian Gene Expression. ChemBioChem. 4(10). 1033–1039. 6 indexed citations

16.

Paddison, Patrick J., Amy A. Caudy, Emily Bernstein, Gregory J. Hannon, & Douglas S. Conklin. (2002). Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes & Development. 16(8). 948–958. 1207 indexed citations breakdown →

17.

McCaffrey, Anton P., Leonard Meuse, Thu-Thao T. Pham, et al.. (2002). RNA interference in adult mice. Nature. 418(6893). 38–39. 849 indexed citations breakdown →

18.

Fitzgerald, Laurence R., John P. Patterson, Douglas S. Conklin, Robert A. Horlick, & B L Largent. (1998). Pharmacological and Biochemical Characterization of a Recombinant Human Galanin GALR1 Receptor: Agonist Character of Chimeric Galanin Peptides. Journal of Pharmacology and Experimental Therapeutics. 287(2). 448–456. 18 indexed citations

19.

Conklin, Douglas S., et al.. (1992). COT1, a Gene Involved in Cobalt Accumulation in Saccharomyces cerevisiae. Molecular and Cellular Biology. 12(9). 3678–3688. 170 indexed citations

20.

Jacobson, Lewis A., Linda Jen‐Jacobson, John M. Hawdon, et al.. (1988). Identification of a putative structural gene for cathepsin D in Caenorhabditis elegans.. Genetics. 119(2). 355–363. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact